MP81-08 COMBINATION THERAPY WITH PARP INHIBITOR AND STATIN FOR CASTRATION-RESISTANT AND TAXANE-RESISTANT PROSTATE CANCER

Authors :: Yoshitaka Sekine
Daisuke Oka
Hiroshi Nakayama
Yasuhiro Shibata
Kazuhiro Suzuki
Hiroshi Matsui
Hidekazu Koike
Yoshiyuki Miyazawa
Source :: Journal of Urology. 201
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Prostate cancer
Statin
Taxane
Combination therapy
medicine.drug_class
business.industry
Urology
PARP inhibitor
medicine
Cancer research
Castration resistant
business
medicine.disease

Full Text Access

Tools